Human papillomavirus genotyping by oligonucleotide microarray and p16 INK4A expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women

Pathology International

Volumn 55, Issue 8, 2005, Pages 491-496

  Lin, Zhen Hua ^a   Shen, Xiong Hu ^a   Jin, Zhe ^b   Kim, Youngsik ^c   Lee, Eungseok ^c   Kim, Hankyeom ^c   Kim, Insun ^c  

^a YANBIAN UNIVERSITY   (China)

^b Department of Internal Medicine   (China)

^c Korea University College of Medicine   (South Korea)

Author keywords

Cervix uteri; Genotype; Human papillomavirus; Oligonucleotide microarray; p16INK4A

Indexed keywords

PROTEIN P16INK4A;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; KOREA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HELA CELLS; HUMANS; KOREA; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 23244456243     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01858.x     Document Type: Article

References (20)

1. Schwarz E, Freese UK, Gissmann L et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111-14.
2. Durst M, Glitz D, Schneider A, zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992; 189: 132-40.
3. Sasagawa T, Basha W, Yamazaki H, Inoue M. High risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomark Prev 2001; 10: 45-52.
4. Milde-Langosch K, Kraus-Poppinghaus SRA, Loning LRT. Expression of cyclin-dependent kinase inhibitors p16MTS1, 21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001; 439: 55-61.
5. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-8.
6. Nakao Y, Yang X, Yokoyama M et al. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer 1997; 75: 1410-16.
7. von Doeberitz MK. New markers for cervical dysplasia to visualize the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002; 38: 2229-42.
8. INK4A, and early endocervical glandular neoplasia. Hum Pathol 2002; 33: 899-904.
9. INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. An immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003; 27: 187-93.
10. Hwang TS, Jeong JK, Park M, Han HS, Choi HK, Park TS. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 2003; 90: 51-6.
11. Kim CJ, Jeong JK, Park M et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003; 89: 210-17.
12. Hwang TS. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999; 14: 593-9.
13. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989; 261: 737-43.
14. Liaw KL, Glass AG, Manos MM et al. Detection of human papillomavirus DNA in cytological normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999; 91: 954-60.
15. Matsukura T, Sugase M. Relationships between 80 human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: association and causality. Virology 2001; 283: 139-47.
16. INK4B alterations in primary gynecologic malignancy. Gynecol Oncol 1997; 65: 319-24.
17. Krul EJ, van de Vijver MJ, Schuuring E, van Kanten RW, Peters AA, Fleuren GJ. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int J Gynecol Cancer 1999; 9: 206-11.
18. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathological lesions. Int J Cancer 1995; 61: 13-22.
19. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802.
20. Park TC, Kim CJ, Koh YM et al. Human papillomavirus genotyping by the DNA Chip in the cervical neoplasia. DNA Cell Biol 2004; 23: 119-25.